Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students (VR-BodySafe)

12 de noviembre de 2026 actualizado por: Edanur Tar Bolacali, Kirsehir Ahi Evran Universitesi

The Effect of Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students on Awareness, Diagnosis and Reporting Attitudes: A Randomized Controlled Trial

The goal of this randomized controlled trial is to learn whether a virtual reality-supported child abuse and body safety education program improves fourth-year nursing students' awareness of child abuse and neglect, their ability to recognize its signs and risk factors, and their attitudes toward reporting it. The main questions it aims to answer are: - Do students who receive the program score higher in recognizing the signs and risks of child abuse and neglect than students who do not? - Do they have higher awareness of child abuse and neglect and more positive attitudes toward reporting child abuse? - Are these effects still present one month after the program ends? Researchers will compare an intervention group, which takes part in an 8-week face-to-face program (one 90-minute session per week) ending with a virtual reality simulation, with a control group that receives no training during the study. Control group students will be offered the same training after the study ends. Participants will: - Complete questionnaires before the program, after the program, and one month later - If assigned to the intervention group, attend weekly education sessions and take part in a short virtual reality simulation in week 8

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Background: Nurses are often the first health professionals to see signs of child abuse and neglect, but nursing students report limited knowledge, limited clinical exposure and uncertainty about legal reporting duties. Technology-based and simulation-based education may help close this gap. Design and setting: Two-arm, parallel-group, pretest-posttest randomized controlled trial with a one-month follow-up, conducted at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University, Kirsehir, Turkiye. The study was approved by the Cankiri Karatekin University Health Sciences Ethics Committee (Meeting No. 33, 12 May 2026) and is funded by the Kirsehir Ahi Evran University Scientific Research Projects Coordination Unit (SYO.A3.26.006). Reporting will follow the CONSORT 2025 statement. Sample size: Calculated with G*Power 3.1.9.2 using Child Abuse and Neglect Symptoms and Risk Diagnosis Scale scores from a similar study (3.39 +/- 0.28 and 3.60 +/- 0.28; effect size 0.75, alpha 0.05, power 0.95), giving 96 students (48 per group). Allowing for attrition, 100 students (50 per group) will be enrolled. Randomization and allocation concealment: After baseline measurements, students will be assigned 1:1 to the intervention or control group by simple randomization using a computer-generated sequence (randomizer.org). Randomization will be performed by an independent researcher not involved in delivering the intervention, and the allocation list will be concealed from the research team until assignment. Masking: Because of the nature of the intervention, participants and educators cannot be masked. Data will be coded (e.g., Group A and Group B) and analyzed by an independent statistician unaware of group allocation. Intervention delivery: Seven weekly face-to-face modules use active learning techniques. In week 8, students take part in the virtual reality game "Look From My World", in which they experience, from a 7-year-old child's point of view, a child's attempt to disclose a body safety violation to a school nurse and compare an inappropriate and an appropriate nursing response. The scenario does not depict abuse. A structured PEARLS debriefing follows. Module content and the scenario were reviewed by experts and will be pilot-tested with nursing students before the trial. Data analysis: IBM SPSS Statistics 29.0. Group x time effects will be tested with two-way repeated measures ANOVA when parametric assumptions are met, or with non-parametric equivalents. Analysis will follow the intention-to-treat principle. The significance level is set at p < 0.05. Safety: Participants may stop the virtual reality application at any time without any consequence. Students with epilepsy or severe motion sickness are excluded. Psychological support and referral information are available during and after the sessions.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

100

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Fourth-year student at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University
  • Has completed the Child Health and Diseases Nursing (Pediatric Nursing) course
  • Has not previously attended a structured education program on child abuse and body safety
  • Volunteers to participate and signs the informed consent form
  • States that they can attend the education sessions and all measurements

Exclusion Criteria:

  • Has received certified training in child abuse, neglect or forensic nursing
  • Is actively working in an institution or project related to child abuse
  • Has a known health condition that may prevent virtual reality use (e.g., severe motion sickness or vertigo, epilepsy)
  • Did not complete the baseline measurements or completed the scales with substantial missing or invalid responses

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: VR-Supported Body Safety Education

Fourth-year nursing students who receive an 8-week face-to-face education program (one 90-minute session per week) on child abuse, neglect and body safety, ending with a virtual reality simulation in week 8.

An 8-week face-to-face program with one 90-minute session per week. Weeks 1-7 cover child maltreatment; child neglect and the nursing approach; types of child abuse (physical, emotional, sexual and cyber abuse); child abuse and the nursing approach, including documentation and legal reporting; interventions for preventing child abuse and neglect; and body safety education for teaching children self-protection skills (two sessions). Each module uses an active learning technique (station technique, six thinking hats, brainstorming, six action shoes, cooperative learning). In week 8, students complete the virtual reality game "Look From My World" (about 6 minutes), experiencing from a 7-year-old child's perspective a disclosure to a school nurse with an inappropriate and an appropriate nursing response, followed by a structured PEARLS debriefing.

Sin intervención: Wait-list Control

Fourth-year nursing students who receive no training during the study and continue their usual curriculum. They will be offered the same program after the one-month follow-up measurement.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Recognition of Signs and Risks of Child Abuse and Neglect
Periodo de tiempo: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Symptoms and Risk Diagnosis Scale (Uysal, 1998), 67 items in 6 subscales rated on a 5-point Likert scale (21 items reverse-scored). Total score ranges from 67 to 335; higher scores indicate better recognition of the signs and risk factors of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Child Abuse and Neglect Awareness
Periodo de tiempo: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Awareness Scale, 20 case-based items in 4 subscales (physical, sexual and emotional abuse, and neglect) rated on a 5-point Likert scale. Total score ranges from 20 to 100; higher scores indicate greater awareness of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention
Attitudes Toward Reporting Child Abuse
Periodo de tiempo: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Turkish version of the Healthcare Provider Attitudes Toward Child Maltreatment Reporting Scale (Singh et al., 2017; Turkish adaptation by Turan and Erdogan, 2019), 21 items rated on a 5-point Likert scale. Total score ranges from 21 to 105; higher scores indicate more positive, responsibility-oriented attitudes toward reporting child abuse.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

17 de noviembre de 2026

Finalización primaria (Estimado)

15 de enero de 2027

Finalización del estudio (Estimado)

28 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

12 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • SYO.A3.26.006

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be shared because participants did not consent to data sharing and the dataset includes sensitive information about participants' own childhood experiences of abuse and neglect. Aggregate results will be published in a peer-reviewed journal.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .